Genexine has ranked among the top searched stocks for 13 days in the past month.


As of 2:31 PM on the 16th, Genexine is trading at 116,800 KRW, up 3.0% from the previous day. This is a 23.56% decrease compared to December 7. Genexine is known as a specialized company in biopharmaceutical development.

Today, foreigners have a net purchase of 2,000 shares of Genexine, while institutions have a net sale of 1,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 131,762 shares, foreigners have net purchased 863 shares, and institutions have net sold 80,121 shares.


On December 15, Genexine was a market issue with the headline "Continued sharp drop due to change in COVID-19 vaccine candidate substance."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing